Join
Live feed
·
INSIDERFilingvia Quantisnow
Neoleukin Therapeutics Inc. logo

SEC Form 4: Patel Priti converted options into 10,000 shares and sold $6,749 worth of shares (5,538 units at $1.22), increasing direct ownership by 223% to 6,462 units (withholding tax)

ByQuantisnow·Wall Street's wire, on your screen.

This insight was delivered by - Wall Street's wire, on your screen. Quantisnow is a real-time market data and news platform for retail investors, aggregating SEC filings, FDA approvals, analyst ratings, insider trading, and press releases into a single customizable feed. Track NLTX (Neoleukin Therapeutics Inc.) and more on Quantisnow.

SEC Form 4: Patel Priti converted options into 10,000 shares and sold $6,749 worth of shares (5,538 units at $1.22), increasing direct ownership by 223% to 6,462 units (withholding tax) | Quantisnow